Synthesized anellovirus particles demonstrated tissue-specific delivery in vivo CAMBRIDGE, Mass., May 02, 2022 (GLOBE NEWSWIRE)…
Management to host conference call and webcast on May 9th at 5:00 pm EDT /…
Preclinical data suggest that SZN-413 can simultaneously address retinal non-perfusion and leakage in blood vessels…
DUBLIN, Ireland, May 02, 2022 (GLOBE NEWSWIRE) — Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical…
DALLAS, May 02, 2022 (GLOBE NEWSWIRE) — Vaxxinity, Inc. (Nasdaq: VAXX), a company pioneering the…
CAMBRIDGE, Mass., May 02, 2022 (GLOBE NEWSWIRE) — Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage…
CAMBRIDGE, Mass., May 02, 2022 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company…
SAN DIEGO, Calif., and SUZHOU, China, May 02, 2022 (GLOBE NEWSWIRE) — Gracell Biotechnologies Inc….
— New data show setmelanotide treatment led to clinically meaningful improvements in lipid parameters, without…
FORT LAUDERDALE, Fla., May 02, 2022 (GLOBE NEWSWIRE) — Motus GI Holdings, Inc., (NASDAQ: MOTS)…
MISSISSAUGA, Ontario, May 02, 2022 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, TSX Venture: RX) is…
MORRISTOWN, N.J., May 02, 2022 (GLOBE NEWSWIRE) — Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT), a biopharmaceutical company…
Five posters include data across biomarker, target engagement, and mechanism studies supporting development of PLN-74809,…
Nes-Ziona, Israel, May 02, 2022 (GLOBE NEWSWIRE) — Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”),…
— Levels of Ki67+ expression by CD8+T cells and NK cells increased by 17-fold and…
MALVERN, Pa., May 02, 2022 (GLOBE NEWSWIRE) — Ocugen, Inc. (NASDAQ: OCGN), a biotechnology company…
Imagene AI team Imagene Founders Jonathan Zalach, Dean Bitan and Shahar Porat, Chief Scientific Officer…
BRIDGEWATER, N.J., May 02, 2022 (GLOBE NEWSWIRE) — Nevakar Injectables Inc. (“Nevakar”), a wholly owned…
Presentations to feature laterally spreading capsid for the treatment of X-linked retinoschisis and dual vector…
Data highlight proprietary allogeneic cell engineering platform capable of creating immune-evading T cells and deployable for…